Department of Surgery

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Liver Transplantation 55%
3. Living Donors 46%
4. Thyroidectomy 45%
5. Breast 43%
6. Robotics 41%
7. Recurrence 39%
8. Neoplasms 36%
9. Papillary Thyroid Cancer 30%
10. Neoplasm Metastasis 28%
11. Colorectal Neoplasms 27%
12. Tissue Donors 26%
13. Survival 23%
14. Triple Negative Breast Neoplasms 22%
15. Safety 22%
16. Liver 21%
17. Regulatory T-Lymphocytes 21%
18. Lymph Nodes 19%
19. Registries 19%
20. Rectal Neoplasms 19%
21. Colonic Neoplasms 19%
22. Stomach Neoplasms 18%
23. Survival Rate 18%
24. Common Bile Duct 17%
25. Transplants 16%
26. Therapeutics 15%
27. Multicenter Studies 15%
28. Estrogen Receptors 15%
29. Hepatocellular Carcinoma 15%
30. Propensity Score 15%
31. Mastectomy 15%
32. Thyroid Neoplasms 14%
33. Segmental Mastectomy 13%
34. Bile Ducts 13%
35. Laparoscopic Cholecystectomy 13%
36. Drug Therapy 12%
37. Hormones 12%
38. Pancreaticoduodenectomy 12%
39. Thyroid Gland 12%
40. Mutation 12%
41. Postoperative Pain 11%
42. Epithelial-Mesenchymal Transition 11%
43. Pancreatectomy 11%
44. Confidence Intervals 11%
45. Laparoscopy 11%
46. Retrospective Studies 11%
47. Kidney Transplantation 11%
48. Graves Disease 11%
49. Tamoxifen 10%
50. Postoperative Complications 10%
51. Hepatectomy 10%
52. Bile Duct Neoplasms 10%
53. Fluorodeoxyglucose F18 10%
54. Appendectomy 10%
55. human ERBB2 protein 9%
56. Sentinel Lymph Node Biopsy 9%
57. Carcinoma 9%
58. Disease-Free Survival 9%
59. Odds Ratio 9%
60. Tacrolimus 9%
61. Serum 9%
62. Nipples 9%
63. Indocyanine Green 9%
64. Kidney 9%
65. Ductal Carcinoma 9%
66. Transforming Growth Factors 9%
67. Reactive Oxygen Species 9%
68. Letrozole 9%
69. Biopsy 8%
70. Adenocarcinoma 8%
71. Length of Stay 8%
72. Neuroendocrine Tumors 8%
73. Pancreatic Neoplasms 8%
74. Randomized Controlled Trials 8%
75. Adjuvant Chemotherapy 8%
76. Organ Transplantation 8%
77. Biomarkers 8%
78. Body Mass Index 8%
79. Margins of Excision 8%
80. Hemorrhoids 7%
81. Incidence 7%
82. alpha-Fetoproteins 7%
83. Databases 7%
84. Transplant Recipients 7%
85. Multivariate Analysis 7%
86. Mammaplasty 7%
87. Cell Line 7%
88. Intussusception 7%
89. Colitis 7%
90. Ligation 7%
91. Familial Breast Cancer 7%
92. Transplantation 7%
93. Ovarian Neoplasms 7%
94. Meta-Analysis 7%
95. Lymph Node Excision 7%
96. Surgeons 7%
97. Pain 7%
98. Matrix Metalloproteinase 7 6%
99. Biliary Tract Neoplasms 6%
100. Cadherins 6%